FibroGen, Inc. (NASDAQ:FGEN) Announces 1-for-25 Reverse Stock Split

Jun 14, 2025 9:00 AM - Alex Lavoie(Last modified: Jun 16, 2025 2:01 PM)

Image credit: Google Images

FibroGen, Inc. (NASDAQ:FGEN) is a leading biopharmaceutical company focused on the development and commercialization of innovative therapies for anemia, fibrotic disease, and cancer. The company has announced a significant corporate action: a 1-for-25 reverse stock split, set to take effect at 5:00 p.m. Eastern Time on June 16, 2025.

This strategic move aims to increase the stock price by reducing the number of shares available, potentially making the stock more attractive to investors. Here's what you need to know about this upcoming change:

- The reverse stock split will result in shareholders receiving 1 share for every 25 shares they currently own. - Currently, FGEN's stock is priced at $0.26, having decreased by 14.46% with a change of -$0.04. - The market capitalization of FGEN is approximately $26.67 million, with a trading volume of 3,900,845 shares on the NASDAQ exchange.

The reverse stock split is a critical step for FibroGen as it seeks to stabilize its stock price and enhance shareholder value. By consolidating shares, the company aims to make its stock more appealing to a broader range of investors. Trading on a split-adjusted basis will commence the day following the split, under the same ticker symbol but with a new CUSIP number, 31572Q881, to reflect the change. This adjustment could have significant implications for the company's stock performance and investor interest moving forward.

Other Blogs

Nov 22, 2024 5:08 AM - Parth Sanghvi

Fundamental Analysis: Principles, Types, and How to Use It

Fundamental analysis is one of the most essential tools for investors and analysts alike, helping them assess the intrinsic value of a stock, company, or even an entire market. It focuses on the financial health and economic position of a company, often using key data such as earnings, expenses, ass...

Dec 17, 2024 8:58 AM - Sanzhi Kobzhan

Examining Tesla’s Financial Health Using FinancialModelingPrep’s Ratios API

Tesla, one of the world’s most talked-about electric vehicle manufacturers, attracts a lot of attention from investors and market watchers. By examining a snapshot of Tesla’s financial ratios—such as those provided by FinancialModelingPrep’s Ratios API—we can get a clearer picture of the company’s f...

Dec 22, 2024 7:59 AM - Sanzhi Kobzhan

Two great Software Platform Stocks Similar to Palantir (PLTR)

When it comes to cutting-edge software and data analytics, Palantir Technologies (NYSE: PLTR) is often front and center. But for many investors, it’s important to consider alternative or complementary stocks in the same sector that may offer robust growth potential. As PLTR looks expensive (overvalu...